#news #biotech Evolus plans $75M IPO to bring Botox biosimilar to market

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Evolus plans $75M IPO to bring Botox biosimilar to market .Evolus has filed for a $75 million IPO. The financing will position Evolus to challenge Allergan’s grip on the wrinkle-busting sector by bringing a biosimilar copy of Botox to market in the U.S. and elsewhere.

from FierceBiotech: Biotech http://ift.tt/2CNRyMw